Canary Wharf Group (CWG) and Kadans Science Partner have appointed Cushman & Wakefield and JLL as joint leasing agents for the 800,000 sq ft health and life sciences cluster they intend to develop at Canary Wharf.
The 23-storey building, which was designed by KPF and is being built on a 3.3 hectare site at North Quay, will be one of the largest wet lab enabled life science buildings in Europe, when construction completes in 2026
Richard Archer, managing director of Canary Wharf Group, said: “The appointment of Cushman & Wakefield and JLL is a reflection of our commitment to assembling a best-in-class team to deliver the biggest and most innovative life sciences development in Europe. We already have a significant amount of interest from potential occupiers in relation to our plans and will aim to start leasing space concurrent with construction. At the same time, we will also look to build on the momentum of the recent leasing to Genomics England at One Canada Square, as we establish a major life science ecosystem Canary Wharf.”
James Sheppard, managing director UK & Ireland at Kadans Science Partner, added: “Both Cushman & Wakefield and JLL have first class specialist life science teams, who will bring exceptional expertise and experience that is highly complementary of our own intrinsic insight into the requirements and modus operandi of the life science and healthcare industry. We are targeting an official marketing launch of the new development at North Quay early next year.”
Paddy Shipp, head of UK life sciences agency at JLL said: “London is an extremely exciting market for the UK’s life science sector where we are seeing significant occupational demand for best in class lab space in London. This landmark development will be truly unique and JLL are thrilled to be working with the joint venture in bringing it forward in the heart of East London’s knowledge cluster.”
Jamie Renison, head of life sciences agency UK at Cushman & Wakefield, added: “This pioneering new development at North Quay will have a transformational effect on the life sciences sector in London, further enhancing the UK’s status as a centre for research, innovation and discovery. We are excited to be helping Canary Wharf Group and Kadans create the environment and ecosystem in which companies have everything they need to flourish and grow, using the strength and connectivity of our global life sciences platform to do so.”
